Healthcare & Life Sciences
Deck Therapeutics
United Stateswww.decktherapeutics.com/
Deck Therapeutics is a Healthcare & Life Sciences startup based in the United States.
Active
About Deck Therapeutics
Deck Therapeutics is a company headquartered in the United States. Brouky classifies it under Healthcare & Life Sciences.
Deck Therapeutics develops THDG3, a semi-synthetic intravenous omega-3 fatty acid glyceride emulsion aimed at neuroprotection for hypoxic-ischemic brain injuries such as neonatal hypoxic-ischemic encephalopathy and ischemic stroke; the compound originated from research at Columbia University.
Explore Deck Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.